|
SECURITIES AND EXCHANGE COMMISSION |
|
|
Washington, D.C. 29549 |
|
|
|
|
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED
PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS
THERETO FILED PURSUANT TO 13d-2(b)
(Amendment No. 8)*
NOVAMED, INC.
(Name of Issuer)
COMMON STOCK, par value $.01 per share
(Title of Class of Securities)
66986W207
(CUSIP Number)
December 31, 2010
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
o |
Rule 13d-1(b) |
o |
Rule 13d-1(c) |
x |
Rule 13d-1(d) |
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
SCHEDULE 13G
CUSIP No. 66986W207 | |||||
| |||||
|
1. |
Name of Reporting Persons | |||
| |||||
|
2. |
Check the Appropriate Box if a Member of a Group* | |||
|
|
(a) |
o | ||
|
|
(b) |
x | ||
| |||||
|
3. |
SEC Use Only | |||
| |||||
|
4. |
Citizenship or Place of Organization | |||
|
|
| |||
Number of |
5. |
Sole Voting Power | |||
| |||||
6. |
Shared Voting Power | ||||
| |||||
7. |
Sole Dispositive Power | ||||
| |||||
8. |
Shared Dispositive Power | ||||
| |||||
|
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person | |||
| |||||
|
10. |
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares* o | |||
| |||||
|
11. |
Percent of Class Represented by Amount in Row (9) | |||
| |||||
|
12. |
Type of Reporting Person* | |||
*SEE INSTRUCTIONS BEFORE FILLING OUT!
SCHEDULE 13G
CUSIP No. 66986W207 | |||||
| |||||
|
1. |
Name of Reporting Persons | |||
| |||||
|
2. |
Check the Appropriate Box if a Member of a Group* | |||
|
|
(a) |
o | ||
|
|
(b) |
x | ||
| |||||
|
3. |
SEC Use Only | |||
| |||||
|
4. |
Citizenship or Place of Organization | |||
|
|
| |||
Number of |
5. |
Sole Voting Power | |||
| |||||
6. |
Shared Voting Power | ||||
| |||||
7. |
Sole Dispositive Power | ||||
| |||||
8. |
Shared Dispositive Power | ||||
| |||||
|
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person | |||
| |||||
|
10. |
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares* o | |||
| |||||
|
11. |
Percent of Class Represented by Amount in Row (9) | |||
| |||||
|
12. |
Type of Reporting Person* | |||
*SEE INSTRUCTIONS BEFORE FILLING OUT!
SCHEDULE 13G
CUSIP No. 66986W207 | |||||
| |||||
|
1. |
Name of Reporting Persons | |||
| |||||
|
2. |
Check the Appropriate Box if a Member of a Group* | |||
|
|
(a) |
o | ||
|
|
(b) |
x | ||
| |||||
|
3. |
SEC Use Only | |||
| |||||
|
4. |
Citizenship or Place of Organization | |||
|
|
| |||
Number of |
5. |
Sole Voting Power | |||
| |||||
6. |
Shared Voting Power | ||||
| |||||
7. |
Sole Dispositive Power | ||||
| |||||
8. |
Shared Dispositive Power | ||||
| |||||
|
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person | |||
| |||||
|
10. |
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares* o | |||
| |||||
|
11. |
Percent of Class Represented by Amount in Row (9) | |||
| |||||
|
12. |
Type of Reporting Person* | |||
*SEE INSTRUCTIONS BEFORE FILLING OUT!
SCHEDULE 13G
CUSIP No. 66986W207 | |||||
| |||||
|
1. |
Name of Reporting Persons | |||
| |||||
|
2. |
Check the Appropriate Box if a Member of a Group* | |||
|
|
(a) |
o | ||
|
|
(b) |
x | ||
| |||||
|
3. |
SEC Use Only | |||
| |||||
|
4. |
Citizenship or Place of Organization | |||
|
|
| |||
Number of |
5. |
Sole Voting Power | |||
| |||||
6. |
Shared Voting Power | ||||
| |||||
7. |
Sole Dispositive Power | ||||
| |||||
8. |
Shared Dispositive Power | ||||
| |||||
|
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person | |||
| |||||
|
10. |
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares* o | |||
| |||||
|
11. |
Percent of Class Represented by Amount in Row (9) | |||
| |||||
|
12. |
Type of Reporting Person* | |||
*SEE INSTRUCTIONS BEFORE FILLING OUT!
SCHEDULE 13G
CUSIP No. 66986W207 | |||||
| |||||
|
1. |
Name of Reporting Persons | |||
| |||||
|
2. |
Check the Appropriate Box if a Member of a Group* | |||
|
|
(a) |
o | ||
|
|
(b) |
x | ||
| |||||
|
3. |
SEC Use Only | |||
| |||||
|
4. |
Citizenship or Place of Organization | |||
|
|
| |||
Number of |
5. |
Sole Voting Power | |||
| |||||
6. |
Shared Voting Power | ||||
| |||||
7. |
Sole Dispositive Power | ||||
| |||||
8. |
Shared Dispositive Power | ||||
| |||||
|
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person | |||
| |||||
|
10. |
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares* o | |||
| |||||
|
11. |
Percent of Class Represented by Amount in Row (9) | |||
| |||||
|
12. |
Type of Reporting Person* | |||
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 66986W207 |
Item 1(a) |
Name of Issuer: | ||
Item 1(b) |
Address of Issuers Principal Executive Offices: Suite 1010 Chicago, Illinois 60606 | ||
| |||
Item 2(a) |
Name of Person Filing: Kent Kirk Family LLC Kirk Eye Center, S.C. Scott H. Kirk, M.D Kent A. Kirk, M.D. | ||
Item 2(b) |
Address of Principal Business Office or, if none, Residence: 7427 Lake Street River Forest, Illinois 60305
Kent Kirk Family LLC 7427 Lake Street River Forest, Illinois 60305
Kirk Eye Center, S.C. 7427 Lake Street River Forest, Illinois 60305
Scott H. Kirk, M.D. 7427 Lake Street River Forest, Illinois 60305
Kent A. Kirk, M.D. 7427 Lake Street River Forest, Illinois 60305 | ||
|
| ||
Item 2(c) |
Citizenship: | ||
|
Scott Kirk Family LLC: |
Delaware |
|
|
Kent Kirk Family LLC: |
Delaware |
|
|
Kirk Eye Center, S.C.: |
Illinois |
|
|
Scott H. Kirk, M.D.: |
U.S.A. |
|
|
Kent A. Kirk, M.D.: |
U.S.A. |
|
CUSIP No. 66986W207 |
Item 2(d) |
Title of Class of Securities: |
Item 2(e) |
CUSIP Number: |
Item 3. |
If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a: |
|
Not Applicable. |
|
|
Item 4. |
Ownership: |
|
(a) |
Amount beneficially owned: |
|
| ||
|
|
Scott Kirk Family LLC: |
220,886 |
|
| |
|
|
Kent Kirk Family LLC: |
256,727 |
|
| |
|
|
Kirk Eye Center, S.C.: |
142,814 |
|
| |
|
|
Scott H. Kirk, M.D.: |
434,230 |
(1)(2) |
| |
|
|
Kent A. Kirk, M.D.: |
417,142 |
(3) |
| |
|
|
|
|
|
| |
|
(b) |
Percent of class: |
|
|
| |
|
|
Scott Kirk Family LLC: |
2.8 |
% |
| |
|
|
Kent Kirk Family LLC: |
3.2 |
% |
| |
|
|
Kirk Eye Center, S.C.: |
1.8 |
% |
| |
|
|
Scott H. Kirk, M.D.: |
5.4 |
%(1)(2) |
| |
|
|
Kent A. Kirk, M.D.: |
5.2 |
%(3) |
| |
CUSIP No. 66986W207 |
|
(c) |
Number of shares as to which person has: Scott Kirk Family LLC: | |
|
|
(i) |
Sole power to vote or to direct the vote: 220,886 |
|
|
(ii) |
Shared power to vote or to direct the vote: -0- |
|
|
(iii) |
Sole power to dispose or to direct the disposition of: 220,886 |
|
|
(iv) |
Shared power to dispose or to direct the disposition of: -0- |
|
|
Kent Kirk Family LLC: | |
|
|
(i) |
Sole power to vote or to direct the vote: 256,727 |
|
|
(ii) |
Shared power to vote or to direct the vote: -0- |
|
|
(iii) |
Sole power to dispose or to direct the disposition of: 256,727 |
|
|
(iv) |
Shared power to dispose or to direct the disposition of: -0- |
|
|
Kirk Eye Center, S.C.: | |
|
|
(i) |
Sole power to vote or to direct the vote: 142,814 |
|
|
(ii) |
Shared power to vote or to direct the vote: -0- |
|
|
(iii) |
Sole power to dispose or to direct the disposition of: 142,814 |
|
|
(iv) |
Shared power to dispose or to direct the disposition of: -0- |
|
|
Scott H. Kirk, M.D.: | |
|
|
(i) |
Sole power to vote or to direct the vote: 70,530 (2) |
|
|
(ii) |
Shared power to vote or to direct the vote: 363,700 (1) |
|
|
(iii) |
Sole power to dispose or to direct the disposition of: 70,530 (2) |
CUSIP No. 66986W207 |
|
|
(iv) |
Shared power to dispose or to direct the disposition of: 363,700 (1) |
|
|
Kent A. Kirk, M.D.: | |
|
|
(i) |
Sole power to vote or to direct the vote: 17,601 |
|
|
(ii) |
Shared power to vote or to direct the vote: 399,541 (3) |
|
|
(iii) |
Sole power to dispose or to direct the disposition of: 17,601 |
|
|
(iv) |
Shared power to dispose or to direct the disposition of: 399,541 (3) |
(1) Dr. Scott Kirk is an officer, director and 50% shareholder of Kirk Eye Center, S.C. In addition, Dr. Scott Kirk is the manager and a member of Scott Kirk Family, LLC. In such capacities, Dr. Scott Kirk may be deemed to be the beneficial owner of the shares directly held by such entities.
(2) Includes 5,857 restricted shares of common stock and 25,666 shares of common stock issuable upon exercise of options that are exercisable within 60 days of December 31, 2010.
(3) Dr. Kent Kirk is an officer, director and 50% shareholder of Kirk Eye Center, S.C. In addition, Dr. Kent Kirk is the manager and a member of Kent Kirk Family, LLC. In such capacities, Dr. Kent Kirk may be deemed to be the beneficial owner of the shares directly held by such entities.
CUSIP No. 66986W207 |
Item 5. |
Ownership of Five Percent or Less of a Class: |
|
Not Applicable. |
| |
Item 6. |
Ownership of More than Five Percent on Behalf of Another Person: |
|
Not Applicable. |
| |
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company: |
|
Not Applicable. |
| |
Item 8. |
Identification and Classification of Members of the Group: |
|
Not Applicable. |
| |
Item 9. |
Notice of Dissolution of Group: |
|
Not Applicable. |
|
|
Item 10. |
Certification: |
|
Not Applicable. |
CUSIP No. 66986W207 |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: February 11, 2011 |
| |
|
| |
|
KIRK EYE CENTER, S.C. | |
|
| |
|
| |
|
By: |
/s/ SCOTT H. KIRK, M.D. |
|
Its: |
President |
CUSIP No. 66986W207 |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: February 11, 2011 |
| |
|
| |
|
SCOTT KIRK FAMILY LLC | |
|
| |
|
By: |
/s/ SCOTT H. KIRK, M.D. |
|
Its: |
Manager |
CUSIP No. 66986W207 |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: February 11, 2011 |
| |
|
| |
|
| |
|
KENT KIRK FAMILY LLC | |
|
| |
|
| |
|
By: |
/s/ KENT A. KIRK, M.D. |
|
Its: |
Manager |
CUSIP No. 66986W207 |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: February 11, 2011 |
| |
|
| |
|
| |
|
By: |
/s/ SCOTT H. KIRK, M.D. |
|
|
Scott H. Kirk, M.D. |
CUSIP No. 66986W207 |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: February 11, 2011 |
| |
|
| |
|
| |
|
By: |
/s/ KENT A. KIRK, M.D. |
|
|
Kent A. Kirk, M.D. |